Condition (MeSH)
Posterior Leukoencephalopathy Syndrome
ClinicalTrials.gov lists 7 trials for Posterior Leukoencephalopathy Syndrome or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Rows recorded per section (log scale)
5 sections measured, none recorded · 1 not measured yet · 1 not computed
7 of the 7 trials are tagged with Posterior Leukoencephalopathy Syndrome itself; the rest are tagged with a narrower condition beneath it.
When did Posterior Leukoencephalopathy Syndrome trials start? (4)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Observational
Top of scale: 4
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2022 | 4 |
| 2020 | 1 |
| 2018 | 1 |
| 2016 | 1 |
No forecast is made for this condition: it averages 0.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 7 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Posterior Leukoencephalopathy Syndrome trials in? (1)
Shown in this order: phase order.
| Phase | Trials |
|---|---|
| Observational | 7 |
How many Posterior Leukoencephalopathy Syndrome trials are recruiting? (3)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 1 |
| Completed | 4 |
| Unknown status | 2 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which publications cover Posterior Leukoencephalopathy Syndrome? (24)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Transcranial direct current stimulation for focal status epilepticus or lateralized periodic discharges in four patients in a critical care setting. | Epilepsia | 2023 | Yes |
| Outcomes in Patients With COVID-19 With Acute Encephalopathy and Coma: An International Prospective Study. | Neurology | 2023 | Yes |
| Emergency management of autonomic dysreflexia with neurologic complications. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne | 2016 | Yes |
| Clinical outcomes and risk factors for posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a multicentric case-control study. | Journal of neurology, neurosurgery, and psychiatry | 2016 | Yes |
| Clinical, imagiological and etiological spectrum of posterior reversible encephalopathy syndrome. | Arquivos de neuro-psiquiatria | 2015 | Yes |
Showing 5 of 24 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.